메뉴 건너뛰기




Volumn 40, Issue 7, 2013, Pages 1122-1125

Appropriate use criteria for amyloid PET imaging cannot replace guidelines: On behalf of the European Association of Nuclear Medicine

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FLORBETABEN; FLORBETAPIR F 18; FLUTEMETAMOL F 18; PITTSBURGH COMPOUND B;

EID: 84879502551     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2415-x     Document Type: Review
Times cited : (10)

References (38)
  • 1
    • 84874824543 scopus 로고    scopus 로고
    • Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
    • 23359661 10.2967/jnumed.113.120618 1:CAS:528:DC%2BC3sXltV2ks7g%3D
    • Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, et al. Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. J Nucl Med. 2013;54:476-90.
    • (2013) J Nucl Med , vol.54 , pp. 476-490
    • Johnson, K.A.1    Minoshima, S.2    Bohnen, N.I.3    Donohoe, K.J.4    Foster, N.L.5    Herscovitch, P.6
  • 2
    • 10744232413 scopus 로고    scopus 로고
    • Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
    • 14991808 10.1002/ana.20009 1:CAS:528:DC%2BD2cXisFKntb8%3D
    • Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306-19.
    • (2004) Ann Neurol , vol.55 , pp. 306-319
    • Klunk, W.E.1    Engler, H.2    Nordberg, A.3    Wang, Y.4    Blomqvist, G.5    Holt, D.P.6
  • 3
    • 33750975078 scopus 로고    scopus 로고
    • Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease
    • 16971697 10.1212/01.wnl.0000240117.55680.0a 1:STN:280: DC%2BD28nmslagsQ%3D%3D
    • Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology. 2006;67:1575-80.
    • (2006) Neurology , vol.67 , pp. 1575-1580
    • Kemppainen, N.M.1    Aalto, S.2    Wilson, I.A.3    Någren, K.4    Helin, S.5    Brück, A.6
  • 4
    • 33847062118 scopus 로고    scopus 로고
    • Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
    • 17065593 10.1212/01.wnl.0000244749.20056.d4 1:STN:280: DC%2BD2s%2FpsFymsA%3D%3D
    • Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 2007;68:501-8.
    • (2007) Neurology , vol.68 , pp. 501-508
    • Edison, P.1    Archer, H.A.2    Hinz, R.3    Hammers, A.4    Pavese, N.5    Tai, Y.F.6
  • 5
    • 56749185181 scopus 로고    scopus 로고
    • Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
    • 18653550 10.1136/jnnp.2007.127878 1:STN:280:DC%2BD1cjktFSgsg%3D%3D
    • Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry. 2008;79:1331-8.
    • (2008) J Neurol Neurosurg Psychiatry , vol.79 , pp. 1331-1338
    • Edison, P.1    Rowe, C.C.2    Rinne, J.O.3    Ng, S.4    Ahmed, I.5    Kemppainen, N.6
  • 6
    • 54049100454 scopus 로고    scopus 로고
    • Imaging amyloid deposition in Lewy body diseases
    • 18794492 10.1212/01.wnl.0000326146.60732.d6 1:STN:280: DC%2BD1cngs1amtw%3D%3D
    • Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, et al. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008;71:903-10.
    • (2008) Neurology , vol.71 , pp. 903-910
    • Gomperts, S.N.1    Rentz, D.M.2    Moran, E.3    Becker, J.A.4    Locascio, J.J.5    Klunk, W.E.6
  • 7
    • 77950535797 scopus 로고    scopus 로고
    • Relationship between atrophy and beta-amyloid deposition in Alzheimer disease
    • 20373343
    • Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 2010;67:317-24.
    • (2010) Ann Neurol , vol.67 , pp. 317-324
    • Chételat, G.1    Villemagne, V.L.2    Bourgeat, P.3    Pike, K.E.4    Jones, G.5    Ames, D.6
  • 13
    • 43849083580 scopus 로고    scopus 로고
    • Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
    • 18339640 10.1093/brain/awn016
    • Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain. 2008;131:1630-45.
    • (2008) Brain , vol.131 , pp. 1630-1645
    • Ikonomovic, M.D.1    Klunk, W.E.2    Abrahamson, E.E.3    Mathis, C.A.4    Price, J.C.5    Tsopelas, N.D.6
  • 14
    • 84857843988 scopus 로고    scopus 로고
    • Early AD pathology in a [C-11]PiB-negative case: A PiB-amyloid imaging, biochemical, and immunohistochemical study
    • 22271153 10.1007/s00401-012-0943-2 1:CAS:528:DC%2BC38Xisl2ktbk%3D
    • Ikonomovic MD, Abrahamson EE, Price JC, Hamilton RL, Mathis CA, Paljug WR, et al. Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study. Acta Neuropathol. 2012;123:433-47.
    • (2012) Acta Neuropathol. , vol.123 , pp. 433-447
    • Ikonomovic, M.D.1    Abrahamson, E.E.2    Price, J.C.3    Hamilton, R.L.4    Mathis, C.A.5    Paljug, W.R.6
  • 15
    • 38149081191 scopus 로고    scopus 로고
    • Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: Proof of mechanism
    • 18191617 10.1016/S1474-4422(08)70001-2 1:CAS:528:DC%2BD1cXis1WmsLw%3D
    • Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, et al. Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7:129-35.
    • (2008) Lancet Neurol , vol.7 , pp. 129-135
    • Rowe, C.C.1    Ackerman, U.2    Browne, W.3    Mulligan, R.4    Pike, K.L.5    O'Keefe, G.6
  • 16
    • 66149104129 scopus 로고    scopus 로고
    • Whole-body biodistribution and radiation dosimetry of 18F-GE067: A radioligand for in vivo brain amyloid imaging
    • 19372469 10.2967/jnumed.108.060756 1:CAS:528:DC%2BD1MXmtV2hsrk%3D
    • Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, et al. Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med. 2009;50:818-22.
    • (2009) J Nucl Med , vol.50 , pp. 818-822
    • Koole, M.1    Lewis, D.M.2    Buckley, C.3    Nelissen, N.4    Vandenbulcke, M.5    Brooks, D.J.6
  • 17
    • 77953937194 scopus 로고    scopus 로고
    • In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir F 18)
    • 20501908 10.2967/jnumed.109.069088 1:CAS:528:DC%2BC3cXosl2ksb4%3D
    • Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir F 18). J Nucl Med. 2010;51:913-20.
    • (2010) J Nucl Med , vol.51 , pp. 913-920
    • Wong, D.F.1    Rosenberg, P.B.2    Zhou, Y.3    Kumar, A.4    Raymont, V.5    Ravert, H.T.6
  • 18
    • 78751546481 scopus 로고    scopus 로고
    • Use of florbetapir-PET for imaging beta-amyloid pathology
    • 21245183 10.1001/jama.2010.2008 1:CAS:528:DC%2BC3MXhtVGrurw%3D
    • Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011;305:275-83.
    • (2011) JAMA , vol.305 , pp. 275-283
    • Clark, C.M.1    Schneider, J.A.2    Bedell, B.J.3    Beach, T.G.4    Bilker, W.B.5    Mintun, M.A.6
  • 19
    • 79954748692 scopus 로고    scopus 로고
    • Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: A multicentre phase 2 diagnostic study
    • 21481640 10.1016/S1474-4422(11)70077-1 1:CAS:528:DC%2BC3MXlt1Sls7c%3D
    • Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, et al. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011;10:424-35.
    • (2011) Lancet Neurol , vol.10 , pp. 424-435
    • Barthel, H.1    Gertz, H.J.2    Dresel, S.3    Peters, O.4    Bartenstein, P.5    Buerger, K.6
  • 20
    • 84858607421 scopus 로고    scopus 로고
    • Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand
    • 22323782 10.2967/jnumed.111.094029
    • Cselényi Z, Jönhagen ME, Forsberg A, Halldin C, Julin P, Schou M, et al. Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand. J Nucl Med. 2012;53:415-24.
    • (2012) J Nucl Med , vol.53 , pp. 415-424
    • Cselényi, Z.1    Jönhagen, M.E.2    Forsberg, A.3    Halldin, C.4    Julin, P.5    Schou, M.6
  • 21
    • 84863869296 scopus 로고    scopus 로고
    • Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: A prospective cohort study
    • 22749065 10.1016/S1474-4422(12)70142-4 1:CAS:528:DC%2BC38XhtV2gtb3E
    • Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: A prospective cohort study. Lancet Neurol. 2012;11:669-78.
    • (2012) Lancet Neurol , vol.11 , pp. 669-678
    • Clark, C.M.1    Pontecorvo, M.J.2    Beach, T.G.3    Bedell, B.J.4    Coleman, R.E.5    Doraiswamy, P.M.6
  • 22
    • 84874222233 scopus 로고    scopus 로고
    • [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: Pooled analysis of four studies
    • 23053137 10.1007/s00401-012-1051-z 1:CAS:528:DC%2BC38XhslKls7zI
    • Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, Buckley C, et al. [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies. Acta Neuropathol. 2012;124:833-45.
    • (2012) Acta Neuropathol , vol.124 , pp. 833-845
    • Rinne, J.O.1    Wong, D.F.2    Wolk, D.A.3    Leinonen, V.4    Arnold, S.E.5    Buckley, C.6
  • 23
    • 70349582720 scopus 로고    scopus 로고
    • Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
    • 19587325 10.1212/WNL.0b013e3181b23564 1:CAS:528:DC%2BD1MXhtVKrsbvF
    • Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Någren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 2009;73:754-60.
    • (2009) Neurology , vol.73 , pp. 754-760
    • Okello, A.1    Koivunen, J.2    Edison, P.3    Archer, H.A.4    Turkheimer, F.E.5    Någren, K.6
  • 24
    • 79953177902 scopus 로고    scopus 로고
    • Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study
    • 21325653 10.1212/WNL.0b013e318212015e 1:STN:280:DC%2BC3M3ot1Klsg%3D%3D
    • Koivunen J, Scheinin N, Virta JR, Aalto S, Vahlberg T, Någren K, et al. Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology. 2011;76:1085-90.
    • (2011) Neurology , vol.76 , pp. 1085-1090
    • Koivunen, J.1    Scheinin, N.2    Virta, J.R.3    Aalto, S.4    Vahlberg, T.5    Någren, K.6
  • 25
    • 0035168927 scopus 로고    scopus 로고
    • Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease
    • 11816784 10.1385/JMN:17:2:101 1:CAS:528:DC%2BD3MXosVKitrg%3D
    • Morris JC, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci. 2001;17:101-18.
    • (2001) J Mol Neurosci , vol.17 , pp. 101-118
    • Morris, J.C.1    Price, J.L.2
  • 27
    • 71849102802 scopus 로고    scopus 로고
    • EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2
    • 19838703 10.1007/s00259-009-1266-y 1:CAS:528:DC%2BD1MXhsVCisb3L
    • Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Någren K, et al. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2093-102.
    • (2009) Eur J Nucl Med Mol Imaging , vol.36 , pp. 2093-2102
    • Kapucu, O.L.1    Nobili, F.2    Varrone, A.3    Booij, J.4    Vander Borght, T.5    Någren, K.6
  • 28
    • 77949267716 scopus 로고    scopus 로고
    • EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2
    • 19838704 10.1007/s00259-009-1265-z 1:CAS:528:DC%2BC3cXhsVyisL0%3D
    • Van Laere K, Varrone A, Booij J, Vander Borght T, Nobili F, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:434-42.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , pp. 434-442
    • Van Laere, K.1    Varrone, A.2    Booij, J.3    Vander Borght, T.4    Nobili, F.5    Kapucu, O.L.6
  • 29
    • 77949266557 scopus 로고    scopus 로고
    • EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
    • 19838702 10.1007/s00259-009-1267-x 1:CAS:528:DC%2BC3cXhsVyitr0%3D
    • Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443-50.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , pp. 443-450
    • Darcourt, J.1    Booij, J.2    Tatsch, K.3    Varrone, A.4    Vander Borght, T.5    Kapucu, O.L.6
  • 34
    • 84869116509 scopus 로고    scopus 로고
    • Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional study
    • 23137949 10.1016/S1474-4422(12)70227-2 1:CAS:528:DC%2BC38Xhs12gt7%2FO
    • Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, et al. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. Lancet Neurol. 2012;11:1057-65.
    • (2012) Lancet Neurol , vol.11 , pp. 1057-1065
    • Fleisher, A.S.1    Chen, K.2    Quiroz, Y.T.3    Jakimovich, L.J.4    Gomez, M.G.5    Langois, C.M.6
  • 35
    • 79551495391 scopus 로고    scopus 로고
    • Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
    • 21280088 10.1002/ana.22248 1:CAS:528:DC%2BC3MXisVCisLs%3D
    • Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69:181-92.
    • (2011) Ann Neurol , vol.69 , pp. 181-192
    • Villemagne, V.L.1    Pike, K.E.2    Chételat, G.3    Ellis, K.A.4    Mulligan, R.S.5    Bourgeat, P.6
  • 37
    • 84874241691 scopus 로고    scopus 로고
    • Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline
    • 23203162 10.1097/WAD.0b013e318279d02a 1:CAS:528:DC%2BC3sXis12rsLk%3D
    • Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, et al. Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Dis Assoc Disord. 2013;27:4-15.
    • (2013) Alzheimer Dis Assoc Disord , vol.27 , pp. 4-15
    • Grundman, M.1    Pontecorvo, M.J.2    Salloway, S.P.3    Doraiswamy, P.M.4    Fleisher, A.S.5    Sadowsky, C.H.6
  • 38
    • 84874948210 scopus 로고    scopus 로고
    • Alzheimer disease: Aβ-independent processes-rethinking preclinical AD
    • 10.1038/nrneurol.2013.21
    • Chételat G. Alzheimer disease: Aβ-independent processes-rethinking preclinical AD. Nat Rev Neurol. 2013. doi: 10.1038/nrneurol.2013.21.
    • (2013) Nat Rev Neurol
    • Chételat, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.